Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Oct 09, 2019 11:17am

128 Views

Post# 30211948

RE:RE:Future

PinnacleX
"Stfu already you sold all your shares get the hell out of here."

LOL!!
Education first, mister!
Try to be polite! It will make you feel better!
Like i wrote yesterday, maybe i will be back, am following this "garbage" from the beginning and it was all together
a good investment! But now the BOD are hiding and manipulating the numbers and lying, as if they did not know the numbers!
They new allready a long time T was not going good, but they told all was well and sales were on track!!!

Will follow closely!!!

Have a good investment Mr. P.

:-)

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal